SGRY SHAREHOLDER ALERT: ADEMI LLP INVESTIGATES WHETHER BUYOUT FAIRLY VALUES SURGERY PARTNERS, INC.
SGRY shareholders will receive just $23.50 per share in an all-cash transaction valued at approximately $5.7 billion in enterprise value; Ademi LLP is investigating the deal price, benefits to company insiders, and restrictions on competing offers CLICK HERE TO JOIN MILWAUKEE, Oct. 26,...
Covered in this story
Call it yourself
No calls on $SGRY yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Surgery Partners Inc →Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.